FR2772273B1 - Correction de la contracture de dupuytren - Google Patents

Correction de la contracture de dupuytren

Info

Publication number
FR2772273B1
FR2772273B1 FR9803320A FR9803320A FR2772273B1 FR 2772273 B1 FR2772273 B1 FR 2772273B1 FR 9803320 A FR9803320 A FR 9803320A FR 9803320 A FR9803320 A FR 9803320A FR 2772273 B1 FR2772273 B1 FR 2772273B1
Authority
FR
France
Prior art keywords
dupuytren
contract
correction
dupuytren contract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9803320A
Other languages
English (en)
French (fr)
Other versions
FR2772273A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADVANDE BIOFACTURES OF CURACAO
Original Assignee
ADVANDE BIOFACTURES OF CURACAO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADVANDE BIOFACTURES OF CURACAO filed Critical ADVANDE BIOFACTURES OF CURACAO
Publication of FR2772273A1 publication Critical patent/FR2772273A1/fr
Application granted granted Critical
Publication of FR2772273B1 publication Critical patent/FR2772273B1/fr
Priority to FR11C0033C priority Critical patent/FR11C0033I2/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
FR9803320A 1997-03-27 1998-03-18 Correction de la contracture de dupuytren Expired - Lifetime FR2772273B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR11C0033C FR11C0033I2 (fr) 1997-03-27 2011-08-18 Correction de la contracture de dupuytren

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/826,015 US6086872A (en) 1997-03-27 1997-03-27 Amelioration of dupuytren's disease

Publications (2)

Publication Number Publication Date
FR2772273A1 FR2772273A1 (fr) 1999-06-18
FR2772273B1 true FR2772273B1 (fr) 2003-04-25

Family

ID=25245473

Family Applications (2)

Application Number Title Priority Date Filing Date
FR9803320A Expired - Lifetime FR2772273B1 (fr) 1997-03-27 1998-03-18 Correction de la contracture de dupuytren
FR11C0033C Active FR11C0033I2 (fr) 1997-03-27 2011-08-18 Correction de la contracture de dupuytren

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR11C0033C Active FR11C0033I2 (fr) 1997-03-27 2011-08-18 Correction de la contracture de dupuytren

Country Status (8)

Country Link
US (2) US6086872A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU733208B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE19813748A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK177324B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (2) FR2772273B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2323530B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO981388L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE522723C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US6022539A (en) * 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
GB0306165D0 (en) * 2003-03-18 2003-04-23 Delta G Ltd Medical treatment
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
PL1846022T3 (pl) * 2005-01-21 2016-06-30 Univ New York State Res Found Sposoby leczenia zarostowego zapalenia torebki stawowej
ITPD20050207A1 (it) 2005-07-07 2007-01-08 Fidia Farmaceutici Nuove composizioni farmaceutiche contenenti acido ialuronico e collagenas nel trattamento topico di ferite, ustioni ed ulcere
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
WO2008100833A2 (en) * 2007-02-13 2008-08-21 Auxilium International Holdings, Inc. Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
JP5649589B2 (ja) 2009-03-06 2015-01-07 ハロザイム インコーポレイテッド マトリックスメタロプロテアーゼ１の温度感受性突然変異体およびその使用
WO2010111525A2 (en) 2009-03-25 2010-09-30 Agee, John, M., Trustee Of The John M. Agee Trust Of August 15, 1996 Treatment of carpal tunnel syndrome by injection of the flexor retinaculum
RU2013123796A (ru) * 2010-10-30 2014-12-10 Исис Инновэйшн Лтд Способ лечения болезни дюпюитрена
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
MX350145B (es) 2011-07-20 2017-08-28 Mediwound Ltd Extracto proteolitico a partir de bromelaina para el tratamiento de trastornos del tejido conectivo.
GB201119089D0 (en) 2011-11-04 2011-12-21 Isis Innovation Treatment of musculoskeletal fibroproliferative disorders
HUE046160T2 (hu) 2012-01-12 2020-02-28 Endo Global Ventures Clostridium histolyticum enzim
EP2852403B1 (en) * 2012-04-30 2018-03-07 Elastomics AB Methods for modification of tissues
WO2014066622A2 (en) 2012-10-24 2014-05-01 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
US20150196625A9 (en) 2013-01-07 2015-07-16 Rudolph D. Paladini Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof
CA2907255C (en) * 2013-03-15 2021-09-21 Biospecifics Technologies Corporation Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
CN110545722B (zh) 2017-03-01 2023-02-03 恩多风投有限公司 用于评估和治疗橘皮组织的装置和方法
AU2018244426B2 (en) * 2017-03-28 2024-09-19 Endo Ventures Limited Improved method of producing collagenase
AU2020366008B2 (en) 2019-10-15 2025-08-28 Biospecifics Technologies Corp. Treatment of uterine fibroids using purified collagenase

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
US5173295A (en) * 1990-10-05 1992-12-22 Advance Biofactures Of Curacao, N.V. Method of enhancing the regeneration of injured nerves and adhesive pharamaceutical formulation therefor
US5393792A (en) * 1991-11-20 1995-02-28 Advance Biofactures Of Curacao, N.V. High dosage topical forms of collagenase
US5589171A (en) 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase

Also Published As

Publication number Publication date
AU733208B2 (en) 2001-05-10
GB9805050D0 (en) 1998-05-06
US6086872A (en) 2000-07-11
NO981388D0 (no) 1998-03-26
GB2323530A (en) 1998-09-30
SE522723C2 (sv) 2004-03-02
NO981388L (no) 1998-09-28
DE19813748A1 (de) 1998-10-01
DK40398A (da) 1998-09-28
GB2323530B (en) 2001-10-10
FR11C0033I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2011-09-23
AU5966198A (en) 1998-10-01
DK177324B1 (da) 2013-01-07
FR2772273A1 (fr) 1999-06-18
SE9800806D0 (sv) 1998-03-12
FR11C0033I2 (fr) 2012-03-16
SE9800806L (sv) 1998-09-28
USRE39941E1 (en) 2007-12-18

Similar Documents

Publication Publication Date Title
FR2772273B1 (fr) Correction de la contracture de dupuytren
EP0968223A4 (en) BIOKON JUGATION OF MACROMOLECULES
CY2012029I2 (el) Nεα μορφη της 5-ομεπραζολης
DE69833228D1 (de) Brückenzünder
DE69738464D1 (de) Photoempfindliche Zusammensetzung
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
BR9800705A (pt) Polimerização de ciclossiloxanos
FI970468A0 (fi) Anvaendningspraoksberoende bokstavsmatning med nummertangenter
EE200000365A (et) Bispidiini uued arütmiavastased ühendid
DE69607710D1 (de) Lichtempfindliche Zusammensetzung
FI974269A0 (fi) Radiosaendare-mottagarestruktur med tvao frekvensomraoden
DE69616104D1 (de) Lichtempfindliche Zusammensetzung
DE69817687D1 (de) Positiv-Fotoresist-Zusammensetzung
ID16838A (id) Komposisi dekafluoropentana
FI972664A0 (fi) Foerseglad saeck med avluftning
DE59803356D1 (de) Schachtofen
ATA189297A (de) Schachtofen
ID17419A (id) Komposisi dekafluoropentana
KR950026510U (ko) 씽크대용 다리
FI974544A0 (fi) Anordning i en med manoeverplats foersedd lastkran
DE69804179D1 (de) Photoempfindliche Zusammensetzung
FI970405A0 (fi) Plattformad traeprodukt med skiktstruktur
FR2763940B1 (fr) Preparation de trifluoromethoxy-2-aniline
KR970013583U (ko) 경화방지용 캡
BR1100811A (pt) Derivados de 1-metil-carbapenema

Legal Events

Date Code Title Description
TP Transmission of property
CP Supplementary protection certificate (spc) filed

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

CR Request for supplementary protection certificate laid open to the public (eec regulation of 18 june 1992)

Free format text: PRODUCT NAME: COLLAGENE CLOSTRIDIUM HISTOLYTICUM; REG. NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

CP Supplementary protection certificate (spc) filed

Effective date: 20110829

CT Granted supplementary protection certificate (spc) for medicine (eec regulation of 18 june 1992)

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Extension date: 20230317

Effective date: 20120316

AV Other action affecting the existence or the validity of an industrial property right

Effective date: 20120215

CY Supplementary certificate of protection granted (eec regulation of 18 june 1992)

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Extension date: 20230317

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20

SPAY Annual fee for spc paid [supplementary protection certificate]

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Year of fee payment: 1

Extension date: 20230317

SPAY Annual fee for spc paid [supplementary protection certificate]

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Year of fee payment: 3

Extension date: 20230317

SPAY Annual fee for spc paid [supplementary protection certificate]

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Year of fee payment: 4

Extension date: 20230317

SPAY Annual fee for spc paid [supplementary protection certificate]

Free format text: PRODUCT NAME: COLLAGENASE CLOSTRIDIUM HISTOLYTICUM; REGISTRATION NO/DATE: EU/1/11/671/001 20110228

Spc suppl protection certif: 11C0033

Filing date: 20110818

Year of fee payment: 5

Extension date: 20230317